4.4 Letter

The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation

Journal

HAEMATOLOGICA
Volume 102, Issue 5, Pages E191-E194

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2016.152017

Keywords

-

Categories

Funding

  1. University Medical Center Mainz (Forschungszentrum Immuntherapie)
  2. Deutsche Forschungsgemeinschaft [TRR156/1 A05]
  3. Deutsche Gesellschaft fur Innere Medizin

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available